Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
3.830
+0.050 (1.32%)
At close: Jul 24, 2026, 4:00 PM EDT
3.794
-0.036 (-0.94%)
After-hours: Jul 24, 2026, 7:57 PM EDT
Plus Therapeutics Market Cap
Plus Therapeutics has a market cap or net worth of $26.36 million as of July 24, 2026. Its market cap has increased by 64.76% in one year.
Market Cap
26.36M
Enterprise Value
11.97M
1-Year Change
64.76%
Ranking
Category
Stock Price
$3.83
ChartMarket Cap Chart
Since November 16, 2000, Plus Therapeutics's market cap has decreased from $165.10M to $26.36M, a decrease of -84.03%. That is a compound annual growth rate of -6.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 26.40M | -62.34% |
| Dec 31, 2025 | 70.10M | 930.88% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -26.17% |
| Dec 30, 2022 | 10.70M | -33.54% |
| Dec 31, 2021 | 16.10M | 65.98% |
| Dec 31, 2020 | 9.70M | 7.78% |
| Dec 31, 2019 | 9.00M | 136.84% |
| Dec 31, 2018 | 3.80M | -64.15% |
| Dec 29, 2017 | 10.60M | -65.58% |
| Dec 30, 2016 | 30.80M | 5.84% |
| Dec 31, 2015 | 29.10M | -35.76% |
| Dec 31, 2014 | 45.30M | -73.86% |
| Dec 31, 2013 | 173.30M | 4.90% |
| Dec 31, 2012 | 165.20M | 33.66% |
| Dec 30, 2011 | 123.60M | -52.91% |
| Dec 31, 2010 | 262.50M | 9.42% |
| Dec 31, 2009 | 239.90M | 136.59% |
| Dec 31, 2008 | 101.40M | -33.73% |
| Dec 31, 2007 | 153.00M | 18.97% |
| Dec 29, 2006 | 128.60M | 10.29% |
| Dec 30, 2005 | 116.60M | 202.07% |
| Dec 31, 2004 | 38.60M | -9.81% |
| Dec 31, 2003 | 42.80M | -23.84% |
| Dec 31, 2002 | 56.20M | 24.89% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actuate Therapeutics | 29.91M |
| ABVC BioPharma | 29.57M |
| Kyntra Bio | 28.46M |
| Actinium Pharmaceuticals | 28.35M |
| Aligos Therapeutics | 28.09M |
| Polyrizon | 27.63M |
| IGC Pharma | 26.32M |
| Evaxion | 25.44M |